Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 02, 2024 08:30 ET | Source: Cerevance

Cerevance Achieves First Milestone in Research Collaboration with Merck

BOSTON, May 02, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, announced the achievement of the first...
April 29, 2024 08:30 ET | Source: Cerevance

Cerevance to Participate at Upcoming Investor Conferences

BOSTON, April 29, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system diseases, today announced that company management will...
April 25, 2024 08:00 ET | Source: Cerevance

Cerevance Adds $47 Million in Series B-1 Extension to Advance Robust Clinical Pipeline

Financing round led by Agent Capital, Bioluminescence, and Double Point Ventures, with participation from new investors MQB Partners and others Proceeds will advance Cerevance’s first-in-class...
April 22, 2024 08:30 ET | Source: Cerevance

Cerevance Publishes CVN293 in ACS Medicinal Chemistry Letters

BOSTON, April 22, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system diseases, today announced that the peer-reviewed...
April 17, 2024 08:30 ET | Source: Cerevance

Cerevance Presents at 35th Symposium on Medicinal Chemistry in Eastern England

BOSTON, April 17, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, today announced plans to deliver an oral...
April 02, 2024 08:30 ET | Source: Cerevance

Cerevance to Participate at the 23rd Annual Needham Virtual Health Care Conference

BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, today announced participation at the...
March 13, 2024 08:30 ET | Source: Cerevance

Cerevance Announces Presentation at Alzheimer’s Research UK Conference

BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, today announced plans to present a...
February 27, 2024 08:30 ET | Source: Cerevance

Cerevance Announces Presentation at AD/PD™ 2024 International Conference

BOSTON, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, today announced plans to present a...
February 22, 2024 08:30 ET | Source: Cerevance

Cerevance to Participate at the TD Cowen 44th Annual Health Care Conference

BOSTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, today announced participation at the...
February 15, 2024 08:30 ET | Source: Cerevance

Cerevance Announces Publication of CVN766 in Bioorganic & Medicinal Chemistry Letters

BOSTON, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, today announced a publication describing...